Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2011 1
2012 1
2013 1
2014 1
2015 1
2016 3
2017 4
2018 5
2019 4
2020 7
2021 8
2022 9
2023 8
2024 12
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Results by year

Filters applied: . Clear all
Page 1
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.
Shafat T, Grupel D, Porges T, Abuhasira R, Belkin A, Deri O, Oster Y, Zahran S, Horwitz E, Horowitz NA, Khatib H, Batista MV, Cortez AC, Brosh-Nissimov T, Segman Y, Ishay L, Cohen R, Atamna A, Spallone A, Chemaly RF, Ramos-Ramos JC, Chowers M, Rogozin E, Oren NC, Keske Ş, Barchad OW, Nesher L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Shafat T, et al. Among authors: keske s. Cancer Med. 2024 Feb;13(3):e6997. doi: 10.1002/cam4.6997. Cancer Med. 2024. PMID: 38400683 Free PMC article.
The Mpox 2024 Outbreak: The Main Challenges.
Keske Ş, Güdücüoğlu H, Ergönül Ö. Keske Ş, et al. Balkan Med J. 2024 Oct 31;41(6):416-418. doi: 10.4274/balkanmedj.galenos.2024.2024-240924. Balkan Med J. 2024. PMID: 39484798 Free PMC article. No abstract available.
Antibiotic overconsumption and resistance in Turkey.
Isler B, Keske Ş, Aksoy M, Azap ÖK, Yilmaz M, Yavuz SŞ, Aygün G, Tigen E, Akalın H, Azap A, Ergönül Ö. Isler B, et al. Among authors: keske s. Clin Microbiol Infect. 2019 Jun;25(6):651-653. doi: 10.1016/j.cmi.2019.02.024. Epub 2019 Mar 4. Clin Microbiol Infect. 2019. PMID: 30844434 Free article. No abstract available.
Management of COVID-19 Cases in Kosova.
Ahmeti S, Keske Ş, Namani-Avdiu S, Ajazaj-Berisha L, Vishaj A, Sadik I, Alimusaj M, Hoti F, Ahmeti H, Sait B, Çakar N, Ergönül Ö. Ahmeti S, et al. Among authors: keske s. Infect Dis Clin Microbiol. 2022 Jun 13;4(2):144-147. doi: 10.36519/idcm.2022.125. eCollection 2022 Jun. Infect Dis Clin Microbiol. 2022. PMID: 38633341 Free PMC article. No abstract available.
Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints.
Isler B, Vatansever C, Özer B, Çınar G, Aslan AT, Falconer C, Bauer MJ, Forde B, Şimşek F, Tülek N, Demirkaya H, Menekşe Ş, Akalin H, Balkan İİ, Aydın M, Tigen ET, Demir SK, Kapmaz M, Keske Ş, Doğan Ö, Arabacı Ç, Yağcı S, Hazırolan G, Bakır VO, Gönen M, Saltoğlu N, Azap A, Azap Ö, Akova M, Ergönül Ö, Can F, Paterson DL, Harris PNA. Isler B, et al. Among authors: keske s. Infect Dis (Lond). 2023 Sep;55(9):607-613. doi: 10.1080/23744235.2023.2226709. Epub 2023 Jun 30. Infect Dis (Lond). 2023. PMID: 37391868
Predicting tuberculosis without knowing test specificity.
Koksalan OK, Keske S, Yasin Y, Kilicaslan Z. Koksalan OK, et al. Among authors: keske s. Lancet Infect Dis. 2016 Nov;16(11):1221-1222. doi: 10.1016/S1473-3099(16)30396-6. Lancet Infect Dis. 2016. PMID: 27788976 No abstract available.
58 results